Inovio Pharmaceuticals(INO)
搜索文档
Inovio Pharmaceuticals(INO) - 2021 Q4 - Earnings Call Transcript
2022-03-02 10:19
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2021 Results Conference Call March 1, 2022 4:30 PM ET Company Participants Ben Matone - Senior Director, IR Dr. Joseph Kim - President and CEO Peter Kies - CFO Dr. Jeffrey Skolnik - SVP, Clinical Development Dr. Kate Broderick - SVP, Research and Development Conference Call Participants Hartaj Singh - Oppenheimer Stephen Willey - Stifel Roger Song - Jefferies Yi Chen - H.C. Wainwright Operator Good afternoon and welcome to the Inovio Pharmaceuticals Fourth Quarte ...
Inovio Pharmaceuticals(INO) - 2021 Q3 - Earnings Call Transcript
2021-11-10 09:15
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2021 Earnings Conference Call November 9, 2021 4:30 PM ET CompanyParticipants Joseph Kim – President and CEO Ben Matone – Senior Director of Investor Relations Peter Kies – Chief Financial Officer Jackie Shea – Chief Operating Officer Laurent Humeau – Chief Scientific Office Jeffrey Skolnik – Senior Vice President of Clinical Development Anza Mammen – Senior Vice President of Clinical Development Kate Broderick – Senior Vice President of Research and Development ...
Inovio Pharmaceuticals (INO) Investor Presentation - Slideshow
2021-10-02 01:09
Powering a New Decade of DNA Medicines September 2021 :INO Forward-Looking Statements This presentation includes statements that are, or may be deemed, "forward-looking statements,"" within the meaning of Section 27A of the Securities Act of 1933, as amended. All statements, other than statements of historical facts, included in this presentation regarding our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans and objectives of management are forward-lo ...
Inovio Pharmaceuticals, Inc. (INO) CEO Joseph Kim Presents at Cantor 2021 Global Healthcare Conference (Transcript)
2021-10-01 04:09
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Cantor 2021 Global Healthcare Conference September 30, 2021 12:40 PM ET Company Participants Joseph Kim - President & Chief Executive Officer Conference Call Participants Charles Duncan - Cantor Fitzgerald Charles Duncan Hello, welcome to the Cantor Global Healthcare Conference for 2021. My name is Charles Dunkin and I'm a Managing Director and Senior Biotechnology analysts with the firm. And today is day four of the conference, and it's been quite a conference, and ...